Jocelyn Reader
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 13
- Chemokine receptors and signaling 5
- Cytokine Signaling Pathways and Interactions 4
- Cancer Cells and Metastasis 3
- Pharmacology 11
- Inflammatory mediators and NSAID effects 11
- Co-authors
- Amy M. Fulton (17 shared papers)Dawn Holt (3 shared papers)Xinrong Ma (10 shared papers)Namita Kundu (10 shared papers)Dana M. Roque (11 shared papers)Olga Goloubeva (6 shared papers)Tyler Kochel (6 shared papers)Yukinori Take (2 shared papers)
- Journals
- Cancers (4 papers)Cancer Research (4 papers)Clinical Cancer Research (2 papers)Breast Cancer Research and Treatment (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jocelyn Reader
29 papers receiving 895 citations
Peers
Comparison fields: 5 of 96
- Pharmacology 234
- Oncology 295
- Cancer Research 143
- Immunology 194
- Reproductive Medicine 69
Countries citing papers authored by Jocelyn Reader
This map shows the geographic impact of Jocelyn Reader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Reader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Reader more than expected).
Fields of papers citing papers by Jocelyn Reader
This network shows the impact of papers produced by Jocelyn Reader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Reader. The network helps show where Jocelyn Reader may publish in the future.
Co-authors
The 25 scholars most cited alongside Jocelyn Reader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 130 | |
| 2 | 2021 | 89 | |
| 3 | 2020 | 88 | |
| 4 | 2013 | 84 | |
| 5 | 1995 | 71 | |
| 6 | 2006 | 66 | |
| 7 | 2013 | 56 | |
| 8 | 2018 | 50 | |
| 9 | 2007 | 47 | |
| 10 | 2016 | 46 | |
| 11 | 2010 | 39 | |
| 12 | 2014 | 30 | |
| 13 | 2019 | 21 | |
| 14 | 2022 | 20 | |
| 15 | 2007 | 17 | |
| 16 | 2019 | 15 | |
| 17 | 2020 | 10 | |
| 18 | 2022 | 8 | |
| 19 | 2021 | 7 | |
| 20 | 2021 | 6 |
About Jocelyn Reader
Jocelyn Reader is a scholar working on Oncology, Pharmacology, Genetics, Psychiatry and Mental health and Molecular Biology, having authored 30 papers that have together received 916 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Estrogen and related hormone effects (9 papers), Cancer, Stress, Anesthesia, and Immune Response (7 papers), Chemokine receptors and signaling (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Cells and Metastasis (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (234 citations), Oncology (295 citations), Cancer Research (143 citations), Immunology (194 citations) and Reproductive Medicine (69 citations). Jocelyn Reader has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Amy M. Fulton, Dawn Holt, Xinrong Ma, Namita Kundu, Dana M. Roque, Olga Goloubeva, Tyler Kochel, Yukinori Take, Cong Fan and Yi Ning. Their work appears in journals such as Cancers, Cancer Research, Clinical Cancer Research, Breast Cancer Research and Treatment and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.